RL14 RL14 Pill - white & yellow capsule/oblong, 14mm
Pill with imprint RL14 RL14 is White & Yellow, Capsule/Oblong and has been identified as Metoprolol Succinate Extended-Release 25 mg. It is supplied by Ohm Laboratories Inc.
Metoprolol is used in the treatment of Heart Failure; Angina; High Blood Pressure; Angina Pectoris Prophylaxis; Heart Attack and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Metoprolol 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RL14 RL14
Metoprolol Succinate Extended-Release
- Imprint
- RL14 RL14
- Strength
- 25 mg
- Color
- White & Yellow
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Cardioselective beta blockers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ohm Laboratories Inc.
- National Drug Code (NDC)
- 63304-0008
- Inactive Ingredients
-
hypromellose 2910 (5 mPa.s),
ethylcellulose (20 mPa.s),
polyethylene glycol 400,
polyethylene glycol 6000,
sucrose,
corn starch,
magnesium silicate,
triethyl citrate,
ferric oxide yellow,
ferrosoferric oxide,
potassium hydroxide,
shellac,
titanium dioxide,
propylene glycol
Note: Inactive ingredients may vary.
Related images for "RL14 RL14"
More about metoprolol
- Check interactions
- Compare alternatives
- Reviews (656)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: cardioselective beta blockers
- Breastfeeding
- En español
Patient resources
- Metoprolol drug information
- Metoprolol (Intravenous) (Advanced Reading)
- Metoprolol Extended-Release Tablets
Other brands
Professional resources
- Metoprolol monograph
- Metoprolol (FDA)
- Metoprolol Succinate (FDA)
- Metoprolol Succinate ER Capsules (FDA)
- Metoprolol Succinate ER Tablets (FDA)
Other brands
Lopressor, Toprol-XL, Kapspargo Sprinkle
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.